II.1)
Scope of the procurement
Cystinosis Diagnosis and Management Advice Service
Reference number:
46441
85000000
-
Health and social work services
Services
II.1.4)
Short description
Cystinosis is a very rare inherited lysosomal storage disease presenting in infancy (95% of cases) with severe kidney disease but subsequently involving multiple organs (eyes, thyroid, liver, diabetes, muscle deterioration). Patients often present to paediatric nephrology services although multi organ disease requires multi-speciality input. Effective drug therapy and renal transplantation has improved the life expectancy of these patients.
This project comprises a provider selection process to commission adult and paediatric cystinosis services.
II.1.6)
Information about lots
This contract is divided into lots:
yes
II.1.7)
Total value of the procurement
Value excluding VAT:
2450000.00
GBP
One hub for adult and paediatric cystinosis services to cover the NHS England population in the North of England
Lot No:
1
II.2.2)
Additional CPV code(s)
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKE -
YORKSHIRE AND THE HUMBER
NUTS code:
UKD -
NORTH WEST (ENGLAND)
NUTS code:
UKC -
NORTH EAST (ENGLAND)
II.2.4)
Description of the procurement
NHS England is seeking to commission a service to deliver cystinosis diagnosis and management advice through the publication of this provider selection process.
Services will be provided from 3 adult and paediatric hubs, either as a joint bid between two organisations (one covering adult services and one covering paediatric services) or as a single integrated service bid from the same organisation, covering both adult and paediatric services. Services will be selected to offer geographically equitable access to minimise patient travel times whilst also offering access to multidisciplinary resources. Services will support national networking of the highly specialised centres with the adult and paediatric centres working closely together to offer an integrated service and excellent transition of patients. The hubs will be required to work in a national network to support the development of national policies and protocols and to facilitate research.
The hub allocation model will be based on a regional lot breakdown as follows:
• Lot 1 - one hub for adult and paediatric cystinosis services to cover the NHS England population in the North of England
• Lot 2 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the Midlands and northern areas of East of England
• Lot 3 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the South of England and southern areas of East of England
Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice.
Criteria below
Quality criterion
-
Name:
Technical
/
Weighting:
100
Price
-
Weighting:
0
II.2.11)
Information about options
Options:
yes
Description of options:
The contract period is 3 years with an option to extend for a further 12 months.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
One hub for adult and paediatric cystinosis services to cover the NHS England population in the Midlands and northern areas of East of England
Lot No:
2
II.2.2)
Additional CPV code(s)
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKH -
EAST OF ENGLAND
NUTS code:
UKG -
WEST MIDLANDS (ENGLAND)
NUTS code:
UKF -
EAST MIDLANDS (ENGLAND)
II.2.4)
Description of the procurement
NHS England is seeking to commission a service to deliver cystinosis diagnosis and management advice through the publication of this provider selection process.
Services will be provided from 3 adult and paediatric hubs, either as a joint bid between two organisations (one covering adult services and one covering paediatric services) or as a single integrated service bid from the same organisation, covering both adult and paediatric services. Services will be selected to offer geographically equitable access to minimise patient travel times whilst also offering access to multidisciplinary resources. Services will support national networking of the highly specialised centres with the adult and paediatric centres working closely together to offer an integrated service and excellent transition of patients. The hubs will be required to work in a national network to support the development of national policies and protocols and to facilitate research.
The hub allocation model will be based on a regional lot breakdown as follows:
• Lot 1 - one hub for adult and paediatric cystinosis services to cover the NHS England population in the North of England
• Lot 2 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the Midlands and northern areas of East of England
• Lot 3 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the South of England and southern areas of East of England
Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice.
Criteria below
Quality criterion
-
Name:
Technical
/
Weighting:
100
Price
-
Weighting:
0
II.2.11)
Information about options
Options:
yes
Description of options:
The contract period is 3 years with an option to extend for a further 12 months.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Lot 3 - one hub for adult and paediatric cystinosis services to cover the NHS England population in the South of England and southern areas of East of England
Lot No:
3
II.2.2)
Additional CPV code(s)
85100000
-
Health services
II.2.3)
Place of performance
NUTS code:
UKK -
SOUTH WEST (ENGLAND)
NUTS code:
UKJ -
SOUTH EAST (ENGLAND)
NUTS code:
UKI -
LONDON
NUTS code:
UKH -
EAST OF ENGLAND
II.2.4)
Description of the procurement
NHS England is seeking to commission a service to deliver cystinosis diagnosis and management advice through the publication of this provider selection process.
Services will be provided from 3 adult and paediatric hubs, either as a joint bid between two organisations (one covering adult services and one covering paediatric services) or as a single integrated service bid from the same organisation, covering both adult and paediatric services. Services will be selected to offer geographically equitable access to minimise patient travel times whilst also offering access to multidisciplinary resources. Services will support national networking of the highly specialised centres with the adult and paediatric centres working closely together to offer an integrated service and excellent transition of patients. The hubs will be required to work in a national network to support the development of national policies and protocols and to facilitate research.
The hub allocation model will be based on a regional lot breakdown as follows:
• Lot 1 - one hub for adult and paediatric cystinosis services to cover the NHS England population in the North of England
• Lot 2 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the Midlands and northern areas of East of England
• Lot 3 – one hub for adult and paediatric cystinosis services to cover the NHS England population in the South of England and southern areas of East of England
Providers wishing to be considered for the delivery of these services will need to respond to the provider selection documentation and submit responses prior to the deadline stated in this notice.
Criteria below
Quality criterion
-
Name:
Technical
/
Weighting:
100
Price
-
Weighting:
0
II.2.11)
Information about options
Options:
yes
Description of options:
The contract period is 3 years with an option to extend for a further 12 months.
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no